| Clinical data | |
|---|---|
| Drug class | Cannabinoid |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H34O2S |
| Molar mass | 374.58 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tinabinol (INN: SP-119) is a synthetic cannabinoid drug that is a sulfur based analogue of dimethylheptylpyran which was patented as an antihypertensive but was never marketed.
| Receptor (ligands) |
| ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||||||||||||||||||||
| Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
This cannabinoid related article is a stub. You can help Wikipedia by adding missing information. |